Daiwa Securities Group Inc. Kala Pharmaceuticals, Inc. Put Options Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KALA
# of Institutions
1Shares Held
1Call Options Held
0Put Options Held
0About Kala Pharmaceuticals, Inc.
- Ticker KALA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,464,160
- Market Cap $9.08M
- Description
- Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...